POSTER: CLL-094 Lisocabtagene Maraleucel (liso-cel) in R/R Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Primary Analysis of the Phase 1/2, Single-Arm, Multicenter TRANSCEND CLL 004 Study
Year: 2023
Type: article
Authors: Tanya Siddiqi, David G. Maloney, Saad S. Kenderian, Danielle M. Brander, Kathleen Dorritie, Jacob Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San-San Ou, Eniko Papp, Yizhe Chen, William Wierda
Institutions: City Of Hope National Medical Center, Augusta University, Ege University, Konya City Hospital, University of Turin, University of Amsterdam, Fred Hutch Cancer Center, Janssen Research & Development (United States), Mayo Clinic, Hospital de Sant Pau, St James's University Hospital, Duke University Health System, University of Pittsburgh, Albert Schweitzer Ziekenhuis, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Copenhagen University Hospital, Massachusetts General Hospital, University of Chicago, Medical College of Wisconsin, Janssen (Belgium), Banner MD Anderson Cancer Center, University of California, San Francisco, Huntsman Cancer Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Hackensack University Medical Center, Hackensack Meridian Health, Northside Hospital, Abramson Cancer Center, University of Pennsylvania, Bristol-Myers Squibb (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4386269950